| |
| |
|
| Insider
Information: |
Rudnick Seth |
| Relationship: |
|
| City: |
Rowayton |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
170,536 |
|
|
Indirect Shares
|
36,411 |
|
|
| Direct
Value |
$21,153 |
|
|
|
Indirect Value
|
$25,194 |
|
|
| Total
Shares |
206,947 |
|
|
| Total
Value |
$46,347 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunicon Corp |
IMMCQ |
Director |
2004-04-21 |
17,269 |
|
0 |
Premium* |
|
|
Epirus Biopharmaceuticals Inc |
EPRS |
Director |
2005-11-15 |
5,486 |
2005-11-15 |
0 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
Director |
2006-05-04 |
9,000 |
|
0 |
Premium* |
|
|
POZEN Inc |
POZN |
Director |
2015-06-23 |
47,501 |
2011-07-25 |
0 |
Premium* |
|
|
Square 1 Financial Inc |
SQBK |
Director |
2015-10-06 |
0 |
2014-06-16 |
1,145 |
Premium* |
|
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-11 |
86,891 |
2017-05-11 |
30,000 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
|
2021-06-29 |
4,389 |
2021-06-29 |
5,266 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMMCQ |
Immunicon Corp |
Director |
– • – |
2004-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
17,269 |
17,269 |
|
- |
|
| EPRS |
Epirus Biopharmaceuticals... |
Director |
– • – |
2005-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
9,749 |
5,486 |
|
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2011-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2012-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5 |
7,500 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2013-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
12,500 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2014-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
9,291 |
21,791 |
0 |
- |
|
| SQBK |
Square 1 Financial Inc |
Director |
• • – |
2014-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
| SQBK |
Square 1 Financial Inc |
Director |
– • – |
2015-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,031 |
32,176 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
9,390 |
31,181 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-23 |
4 |
OE |
$3.93 |
$168,101 |
D/D |
39,697 |
61,488 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-23 |
4 |
D |
$12.02 |
$168,124 |
D/D |
(13,987) |
47,501 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-23 |
4 |
OE |
$3.93 |
$168,101 |
D/D |
39,697 |
61,488 |
0 |
- |
|
| POZN |
POZEN Inc |
Director |
– • – |
2015-06-23 |
4 |
D |
$12.02 |
$168,124 |
D/D |
(13,987) |
47,501 |
0 |
- |
|
| SQBK |
Square 1 Financial Inc |
Director |
– • – |
2015-10-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(31,145) |
0 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
47,501 |
47,501 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
64,391 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-11 |
4 |
B |
$4.77 |
$143,121 |
D/D |
30,000 |
94,391 |
2.39 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
64,391 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2016-11-23 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
30,000 |
0 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-03-15 |
4 |
B |
$2.26 |
$33,950 |
D/D |
15,000 |
79,391 |
2.39 |
- |
|
| ARLZ |
Aralez Pharmaceuticals In... |
Director |
– • – |
2017-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
86,891 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
Director |
– • – |
2017-05-22 |
4 |
A |
$0.00 |
$0 |
I/I |
2,757 |
58,282 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-08-06 |
4 |
AS |
$50.69 |
$506,901 |
D/D |
(10,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-08-06 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
|
– • – |
2018-09-04 |
4 |
OE |
$0.39 |
$3,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
